RxDoctor Payments Data

Alfredo Bou Prieto, MD

Dermatology · Bayamon, PRNPI 1285049635

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 31.5% of the total. Reporting peaked in 2019 at $944 and has fallen 74.6% since, to $240 in 2023. That places this record below the midpoint for dermatology clinicians in PR, where the typical reported total is $1,906.

$1,911in general payments, 2019–2025

Across 20 payments — averaging $95.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$601
  • Sanofi$337
  • Janssen Scientific Affairs, LLC$125
  • Genentech USA, Inc.$125
  • Amgen$125
  • Lilly USA, LLC$100
  • plus $497 from 6 others

What the payments were for

  • Food & beverage$1,84196%
  • Education$704%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,911 in reported general payments places this provider in the 50th percentile of 108 dermatology providers in Puerto Rico.

See all dermatology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$6,538
Medicare patients
20
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Valerate646$23,247
Mometasone Furoate521$18,048
Ketoconazole656$14,935
Metronidazole230$11,200
Clobetasol Propionate145$7,153
Triamcinolone Acetonide706$6,899
Ciclopirox172$5,561
Permethrin55$3,710
Mupirocin153$1,541
Clindamycin Phosphate48$1,455
Lidocaine13$1,247
Ivermectin17$1,004
Fluorouracil11$904
Hydrocortisone112$785
Doxycycline Hyclate48$670

Paid to pharmacies, not to this prescriber.

Other dermatology in Bayamon

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →